Drug Development, Pharmacokinetics and Imaging - 18 January
A one-week module of the MSc in Experimental Therapeutics programme. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the module will be led by Dr Paul Brennan, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists.
Date: Monday 18 to Friday 22 Jan 2016
Venue: Department for Continuing Education, Rewley House, Oxford
This course is aimed at qualified doctors, especially specialist registrars in clinical pharmacology or in training for other medical sub-specialities; clinical research fellows in other specialities; pharmacists; nurses; graduates working in the pharmaceutical industry.
The Pharmacokinetics and Drug Therapy course will provide students with the opportunity to learn more about and discuss the following topics:
- Introduction to pharmacokinetics; absorption, distribution, elimination
- Single intravenous and oral dose kinetics
- Multiple oral dose kinetics, bioavailability and dosage regimens
- The role of PK in drug development and regulatory approval
- Screening and target validation strategies
- Rational drug design using protein structures
- Principles of medicinal chemistry and modulation of drug properties
- Using non-invasive imaging to assess clinical response
- Illustration of the drug development process using case studies
Find out more: Drug Development, Pharmacokinetics and Imaging course page
Contact us: Sarah Kelly +44 (0)1865 286 955
Oxford University retains top spot for spinout generation in the UK
Oxford launches new multi-disciplinary ZERO Institute
Researchers develop the world's first power-free frequency tuner using nanomaterials
New adaptable smart window coating could help heat or cool a home and save energy
Oxford University contributed £15.7 billion to the UK economy in 2018/19